Holen Sie sich die Stockscreener-App
1.105
0.45%
-0.005
Schlusskurs vom Vortag:
$1.11
Offen:
$1.16
24-Stunden-Volumen:
17,622
Relative Volume:
0.03
Marktkapitalisierung:
$5.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-7.10M
KGV:
-0.2083
EPS:
-5.3059
Netto-Cashflow:
$-8.30M
1W Leistung:
-3.07%
1M Leistung:
-13.67%
6M Leistung:
-14.34%
1J Leistung:
-77.49%
1-Tages-Spanne:
$1.08
$1.16
1-Wochen-Bereich:
$1.06
$1.175
52-Wochen-Spanne:
$0.9509
$5.87
Dermata Therapeutics Inc Stock (DRMA) Company Profile
Firmenname
Dermata Therapeutics Inc
Sektor
Branche
Telefon
(858)-223-0882
Adresse
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Compare DRMA vs VRTX, MRNA, REGN, ARGX, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DRMA
Dermata Therapeutics Inc
|
1.105 | 5.65M | 0 | -7.10M | -8.30M | -5.3059 |
VRTX
Vertex Pharmaceuticals Inc
|
504.73 | 133.37B | 12.34B | 4.34B | 3.71B | 16.87 |
MRNA
Moderna Inc
|
190.01 | 79.40B | 2.23B | -3.19B | -1.60B | -8.1462 |
REGN
Regeneron Pharmaceuticals Inc
|
735.20 | 81.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.21 | 60.03B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
206.64 | 43.93B | 742.00K | -1.37B | -1.07B | -7.0731 |
Dermata Therapeutics Inc Aktie (DRMA) Neueste Nachrichten
Dermata Therapeutics, Inc.Common Stock (NQ: DRMA - FinancialContent
12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga
Dermata Therapeutics Stock Price Forecast. Should You Buy DRMA? - StockInvest.us
Dermata Therapeutics Inc. Warrant (DRMAW) Peer Comparison – Compare with Others - Value Research
Dermata Therapeutics Inc. Warrant (DRMAW) Financials – Balance Sheet, Profit & Loss, Cash Flow - Value Research
Dermata Therapeutics Inc. Warrant (DRMAW) Key Financial Ratios – Valuation, Profitability & More - Value Research
Dermata Therapeutics (DRMA) Drops 8.22% to $1.34 as Selling Pressure Drags Micro-Cap Biotech LowerMAMA Signal - vinanet.vn
Dermata Therapeutics (DRMA) Slides 8.22% as Shares Press Toward Key $1.27 SupportPrice Target - dars.gov.et
Dermata launches first direct-to-consumer skincare product By Investing.com - Investing.com UK
Dermata Therapeutics Announces Commercial Launch of Tome Foundational Treatment - Yahoo Finance
Dermata (DRMA) Latest Quarter: Reported EPS Misses Expectations in the Current Update; Closing Move: Shares Move 2.90% Up for the Current SessionAnnual Report - vinanet.vn
Dermata (DRMA) Latest Quarter: Reported EPS Misses Expectations in the Current Update; Closing Move - careplusvn.com
Dermata Therapeutics (NASDAQ:DRMA) Commercial Strategy Gains Attention - kalkinemedia.com
Dermata opens preorders for Tome skincare product - Investing.com
Dermata opens preorders for Tome skincare product By Investing.com - Investing.com Canada
Dermata Announces Preorders Now Open for Tome Foundational Treatment Ahead of Commercial Launch - Newswire.com
Dermata (DRMA) Results Check: EPS Comes in Below Forecast in the Latest Reading; Market Response: Shares Move 2.80% Up for the Current SessionStrong Earnings Momentum - vinanet.vn
Dermata (NASDAQ: DRMA) ends Nasdaq listing for warrants - Stock Titan
Dermata Therapeutics raises $3.4 million in private placement - Investing.com
Dermata Therapeutics Announces Private Placement to Fund DTC Pivot - TipRanks
Form 8K Dermata Therapeutics Inc For: 17 August By Investing.com - Investing.com South Africa
Dermata Therapeutics raises $3.4 million in private placement By Investing.com - Investing.com Canada
Dermata Therapeutics Announces $3.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - ACCESS Newswire
Dermata Therapeutics Raises $3.2 Million in Private Placement; Investors Get Resale Rights - TradingView
Dermata Therapeutics, Inc. announced that it expects to receive $3.347307 million in funding - marketscreener.com
DRMA Q2 2026 Earnings: Wider-Than-Expected Loss Despite 13.8% Share Price AdvanceGross Profit Margin - vinanet.vn
Why CoreWeave Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - Sahm
DRMA|Dermata Therapeutics Inc|Price:1.370|Chg%:+0.290 - TradingKey
Dermata Therapeutics Stock Surges 27% Pre-Market: Why is it Moving? - webull.com
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
Unusual volume stocks are being observed in Wednesday's session. - ChartMill
The market is filled with gapping stocks in Wednesday's session. - ChartMill
DRMA Stock In Focus As Dermata Pivots To Direct-To-Consumer Skincare - timothysykes.com
DRMA Stock Draws Traders As Dermata Pivots To Skincare - StocksToTrade
Went from a daytrader to a swing trader just like that... - Moomoo
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
DRMA Stock Draws Traders As Dermata Pivots To Skincare Launch - StocksToTrade
DERMATA THERAPEUTICS ($DRMA) Releases Q2 2026 Earnings, Stock Rises - Quiver Quantitative
Dermata Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Trending Stocks Today | Dermata Therapeutics Soars 35.18% Post-Market - Moomoo
Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Second Quarter 2026 - ACCESS Newswire
DRMA Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Dermata Therapeutics (DRMA) faces going concern warning amid higher losses and cash burn - Stock Titan
Dermata's Tome Skincare Product Is Designed for Once-Weekly Use - Stock Titan
Dermata Therapeutics Inc expected to post a loss of 55 cents a shareEarnings Preview - TradingView
Dermata Therapeutics Inc (NASDAQ: DRMA) Share Price, DRMA Stock News, DRMA Share Price & Updates - kalkine.com.au
Dermata Therapeutics Announces Commercial Launch Date for Tome(TM) Foundational Treatment - webull.com
Dermata Therapeutics Launches Tome Foundational Skincare Line - TipRanks
Dermata to launch first consumer skincare product Aug. 25 - Investing.com
Dermata to launch first consumer skincare product Aug. 25 By Investing.com - Investing.com South Africa
Finanzdaten der Dermata Therapeutics Inc-Aktie (DRMA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Dermata Therapeutics Inc-Aktie (DRMA) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Bedoya-Toro Munera Maria E | SVP, Regulatory Affairs |
Feb 17 '26 |
Buy |
1.27 |
1,000 |
1,270 |
1,012 |
0.05%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):